The current valuation score of Krystal Biotech Inc is 7.41, ranking 236 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is 44.33, which is 904.85% below the recent high of 445.49 and 348.77% above the recent low of -110.29.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.